414 related articles for article (PubMed ID: 18532984)
21. Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence.
Narasipura SD; Chaturvedi V; Chaturvedi S
Mol Microbiol; 2005 Mar; 55(6):1782-800. PubMed ID: 15752200
[TBL] [Abstract][Full Text] [Related]
22. Cryptococcal lipid metabolism: phospholipase B1 is implicated in transcellular metabolism of macrophage-derived lipids.
Wright LC; Santangelo RM; Ganendren R; Payne J; Djordjevic JT; Sorrell TC
Eukaryot Cell; 2007 Jan; 6(1):37-47. PubMed ID: 17099081
[TBL] [Abstract][Full Text] [Related]
23. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
mBio; 2016 May; 7(3):. PubMed ID: 27165800
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line.
Ganendren R; Carter E; Sorrell T; Widmer F; Wright L
Microbes Infect; 2006 Apr; 8(4):1006-15. PubMed ID: 16487740
[TBL] [Abstract][Full Text] [Related]
25. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans.
Petzold EW; Himmelreich U; Mylonakis E; Rude T; Toffaletti D; Cox GM; Miller JL; Perfect JR
Infect Immun; 2006 Oct; 74(10):5877-87. PubMed ID: 16988267
[TBL] [Abstract][Full Text] [Related]
26. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans.
Walton FJ; Idnurm A; Heitman J
Mol Microbiol; 2005 Sep; 57(5):1381-96. PubMed ID: 16102007
[TBL] [Abstract][Full Text] [Related]
27. Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach.
Tang RJ; Breger J; Idnurm A; Gerik KJ; Lodge JK; Heitman J; Calderwood SB; Mylonakis E
Infect Immun; 2005 Dec; 73(12):8219-25. PubMed ID: 16299318
[TBL] [Abstract][Full Text] [Related]
28. A new hexose transporter from Cryptococcus neoformans: molecular cloning and structural and functional characterization.
Chikamori M; Fukushima K
Fungal Genet Biol; 2005 Jul; 42(7):646-55. PubMed ID: 15907385
[TBL] [Abstract][Full Text] [Related]
29. Nitrogen metabolite repression of metabolism and virulence in the human fungal pathogen Cryptococcus neoformans.
Lee IR; Chow EW; Morrow CA; Djordjevic JT; Fraser JA
Genetics; 2011 Jun; 188(2):309-23. PubMed ID: 21441208
[TBL] [Abstract][Full Text] [Related]
30. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis.
Mylonakis E; Ausubel FM; Perfect JR; Heitman J; Calderwood SB
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15675-80. PubMed ID: 12438649
[TBL] [Abstract][Full Text] [Related]
31. Virulence factors of Cryptococcus neoformans.
Hamilton AJ; Goodley J
Curr Top Med Mycol; 1996 Dec; 7(1):19-42. PubMed ID: 9504057
[TBL] [Abstract][Full Text] [Related]
32. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
Mylonakis E; Moreno R; El Khoury JB; Idnurm A; Heitman J; Calderwood SB; Ausubel FM; Diener A
Infect Immun; 2005 Jul; 73(7):3842-50. PubMed ID: 15972469
[TBL] [Abstract][Full Text] [Related]
33. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model.
Santangelo R; Zoellner H; Sorrell T; Wilson C; Donald C; Djordjevic J; Shounan Y; Wright L
Infect Immun; 2004 Apr; 72(4):2229-39. PubMed ID: 15039347
[TBL] [Abstract][Full Text] [Related]
34. UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans.
Moyrand F; Lafontaine I; Fontaine T; Janbon G
Eukaryot Cell; 2008 Dec; 7(12):2069-77. PubMed ID: 18820075
[TBL] [Abstract][Full Text] [Related]
35. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection.
Nosanchuk JD; Ovalle R; Casadevall A
J Infect Dis; 2001 Apr; 183(7):1093-9. PubMed ID: 11237835
[TBL] [Abstract][Full Text] [Related]
36. Influence of indinavir on virulence and growth of Cryptococcus neoformans.
Monari C; Pericolini E; Bistoni G; Cenci E; Bistoni F; Vecchiarelli A
J Infect Dis; 2005 Jan; 191(2):307-11. PubMed ID: 15609242
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System.
Hamed MF; Araújo GRS; Munzen ME; Reguera-Gomez M; Epstein C; Lee HH; Frases S; Martinez LR
mBio; 2023 Apr; 14(2):e0264022. PubMed ID: 36786559
[TBL] [Abstract][Full Text] [Related]
38. Cryptococcal phospholipase B1 is required for intracellular proliferation and control of titan cell morphology during macrophage infection.
Evans RJ; Li Z; Hughes WS; Djordjevic JT; Nielsen K; May RC
Infect Immun; 2015 Apr; 83(4):1296-304. PubMed ID: 25605772
[TBL] [Abstract][Full Text] [Related]
39. Identification of a Zds-like gene ZDS3 as a new mediator of stress resistance, capsule formation and virulence of the human pathogenic yeast Cryptococcus neoformans.
Li Z; Sun Z; Li D; Pan J; Zhu X
FEMS Yeast Res; 2011 Nov; 11(7):529-39. PubMed ID: 21726407
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the model pathogenic fungus Cryptococcus neoformans.
Idnurm A; Bahn YS; Nielsen K; Lin X; Fraser JA; Heitman J
Nat Rev Microbiol; 2005 Oct; 3(10):753-64. PubMed ID: 16132036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
